Etoposide for HLH: the limits of efficacy

Stephan Ehl¹

Affiliations

PMID: 29269529
DOI: 10.1182/blood-2017-10-808543

Free article

Comment

Etoposide for HLH: the limits of efficacy

Stephan Ehl. Blood. 2017.

Free article

. 2017 Dec 21;130(25):2692-2693.

doi: 10.1182/blood-2017-10-808543.

Author

Stephan Ehl¹

Affiliation

¹ UNIVERSITY OF FREIBURG.

PMID: 29269529
DOI: 10.1182/blood-2017-10-808543

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The author declares no competing financials interests.

Comment on

Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.
Bergsten E, Horne A, Aricó M, Astigarraga I, Egeler RM, Filipovich AH, Ishii E, Janka G, Ladisch S, Lehmberg K, McClain KL, Minkov M, Montgomery S, Nanduri V, Rosso D, Henter JI. Bergsten E, et al. Blood. 2017 Dec 21;130(25):2728-2738. doi: 10.1182/blood-2017-06-788349. Epub 2017 Sep 21. Blood. 2017. PMID: 28935695 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Etoposide for HLH: the limits of efficacy

Affiliation

Etoposide for HLH: the limits of efficacy

Author

Affiliation

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources